This is a type of thyroid cancer that has two main types of cells growing together. It's a common type of thyroid cancer.
Every report comes from a Lived member, sent anonymously.
Have you had Thyroid Surgery for Papillary and Follicular Carcinoma?
Papillary and follicular carcinoma is a thyroid cancer that shows features of two growth patterns at once. Its cells are arranged mostly in small round sacs called follicles, the structures a normal thyroid uses to store hormone, but the cells themselves have the distinctive appearance of papillary thyroid cancer. Today doctors usually call it the follicular variant of papillary thyroid cancer. It is the most common subtype of papillary cancer, which is in turn the most common thyroid cancer, and it is generally treated the same way and carries the same favorable outlook when found early. The thyroid is a butterfly-shaped gland at the front of the neck that makes hormones controlling how the body uses energy. This cancer usually appears as a lump (nodule) in the gland and often causes no symptoms at first, so it is frequently found during a routine exam or on a scan done for another reason. The name is easy to confuse with follicular thyroid cancer, which is a separate type: it rarely spreads to lymph nodes in the neck but can spread through the bloodstream to the lungs or bones.
There is usually no single identifiable cause. Like other papillary thyroid cancers, it develops when thyroid cells acquire changes that let them grow out of control, and several factors make that more likely. Thyroid cancer is almost three times as common in women as in men and is most often diagnosed in women in their 40s or 50s and in men in their 60s or 70s. Radiation to the head or neck in childhood, whether from cancer treatment or nuclear fallout, raises the risk, and the effect is strongest with higher doses and younger age. Excess body weight is also linked to higher risk. Having a parent, sibling or child with thyroid cancer increases risk, although most people with thyroid cancer have no family history of it. A few uncommon inherited conditions, such as familial adenomatous polyposis and Cowden syndrome, carry a higher chance of papillary or follicular-type thyroid cancers. These are associations, and having a risk factor does not mean someone will develop the disease.
Evaluation usually starts when a nodule is felt or seen on imaging. An ultrasound of the neck shows the nodule's size, whether it is solid or filled with fluid and whether nearby lymph nodes look abnormal. A fine-needle aspiration biopsy, in which a thin needle guided by ultrasound draws cells from the nodule, is the main test for cancer. Blood tests check thyroid hormone levels, and a doctor may look at the vocal cords before surgery to see whether they move normally. Needle samples do not always settle the question, because this variant can look similar to harmless follicular nodules. When the result is unclear, surgeons may remove the affected half of the thyroid so a pathologist can examine the whole nodule. That examination matters a great deal. If the tumor is fully enclosed in a capsule with no invasion through it or into blood vessels, it is now classified as a noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP), a very low-risk tumor that is no longer called cancer. In the study that led to the new name, none of 109 people with such tumors had a recurrence over 10 to 26 years, many of them after removing only half the thyroid. Tumors that invade their capsule or blood vessels, or that grow without a capsule, are treated as cancer. Staging describes how far the cancer has spread and depends partly on age. For people under 55, the cancer is stage I unless it has spread to distant parts of the body such as the lungs or bones. For people 55 and older, the stage also depends on the tumor's size and whether it has grown beyond the thyroid or into lymph nodes. Because the type of thyroid cancer can be hard to pin down, it is reasonable to ask that samples be reviewed by a pathologist experienced in thyroid disease.
Surgery is the main treatment. A lobectomy removes only the half of the thyroid containing the tumor and is often enough for small cancers confined to the gland and for NIFTP. A total or near-total thyroidectomy removes all or nearly all of the gland and is more common for larger tumors or higher-risk features; lymph nodes in the neck are removed if the cancer has spread to them. The choice involves a real trade-off. Keeping half the thyroid may avoid the need for hormone pills, but it makes the thyroglobulin blood test used to watch for recurrence harder to interpret. Possible complications include hoarseness or voice changes from irritation or injury to the nerves of the voice box, and low blood calcium if the nearby parathyroid glands are disturbed. These complications are less likely with an experienced thyroid surgeon, and most people go home within a day. Radioactive iodine therapy may follow a thyroidectomy when the risk of recurrence is higher or the cancer has spread. Taken as a pill or liquid, the radioactive iodine is absorbed almost only by thyroid cells, so it can destroy remaining thyroid tissue and cancer cells with little effect on the rest of the body. Its benefit is less clear for small cancers that have not spread. Preparation usually involves a low-iodine diet for one to two weeks and either stopping thyroid hormone pills for several weeks or receiving injections of a lab-made thyroid-stimulating hormone. Afterward, people follow instructions to limit others' radiation exposure for a period, and side effects can include dry mouth, swollen salivary glands and taste changes. Breastfeeding has to stop beforehand, and doctors usually advise avoiding pregnancy for at least six months. After the whole thyroid is removed, a daily thyroid hormone pill (levothyroxine) is needed for life to replace what the gland made. For cancers with a higher chance of returning, doctors may prescribe somewhat higher doses to keep thyroid-stimulating hormone (TSH), which can encourage thyroid cancer growth, very low. That benefit is weighed against the risk of a fast or irregular heartbeat and bone thinning over time. For advanced cancer that has spread and no longer absorbs radioactive iodine, targeted drugs called tyrosine kinase inhibitors, such as sorafenib or lenvatinib, block signals tumors need to grow. External radiation and surgery on areas of spread are other options. At this stage, treatment usually aims to control the cancer and relieve symptoms rather than cure it.
Most people with this cancer do very well. In US national data for papillary thyroid cancer, 5-year relative survival is above 99% when the cancer is confined to the thyroid and 99% when it has reached nearby lymph nodes or tissues, falling to about 71% when it has spread to distant organs. A relative survival figure compares people with the cancer to people without it, so 99% means nearly the same chance of being alive five years later. These are population estimates, not predictions for any one person. After thyroid surgery, the scar across the front of the neck tends to fade over time. For people taking levothyroxine, the dose is adjusted with periodic blood tests until hormone levels settle where the care team wants them. Many people find it hard not to worry about the cancer returning, and that concern is very common. Follow-up continues for years because these cancers grow slowly. Neck ultrasounds usually begin 6 to 12 months after treatment, along with regular blood tests of TSH. After a thyroidectomy, doctors also measure thyroglobulin, a protein made by thyroid tissue, since a rising level can signal that cancer has returned. Roughly 10% to 30% of people who seem cancer-free after initial treatment later have a recurrence, most often in the neck, and it can appear 10 to 20 years later. Treatment for a recurrence may include further surgery, radioactive iodine or, for cancer that has stopped absorbing iodine, targeted drugs.
Arrange a medical visit for a lump or swelling in the neck, a hoarse or changed voice that does not get better, or ongoing trouble or pain with swallowing or breathing. These usually have other causes, but they deserve evaluation, and breathing trouble that is getting worse should be seen promptly. After thyroid surgery, contact the surgical team promptly for numbness or tingling in the face or lips or muscle spasms, which can signal low calcium, and for bleeding, redness or mild swelling at the incision or a fever of 100.5°F (38°C) or higher. In the first days after surgery, call 911 for neck swelling that grows quickly, trouble breathing or a tight feeling in the throat, which can mean bleeding is pressing on the airway, or for severe muscle cramps or spasms with trouble breathing. Between follow-up visits, tell the care team about anything new in the neck or ongoing changes in how you feel on thyroid hormone, such as a racing or irregular heartbeat, so the dose can be checked.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Papillary and Follicular Carcinoma is like, what's helped you, or ask the community a question.